Today: 15 May 2026
Sunbelt Rentals Holdings starts $1.5 billion buyback after NYSE debut, buys 663,882 shares in first week

Sunbelt Rentals Holdings starts $1.5 billion buyback after NYSE debut, buys 663,882 shares in first week

London, March 9, 2026, 21:51 GMT.

Sunbelt Rentals Holdings disclosed Monday it repurchased 663,882 shares between March 2 and March 6—marking the first such update since the company’s main listing moved to New York and it kicked off its $1.5 billion buyback program. These shares will sit in treasury for the time being, the firm added.

Investors now get an early look at Sunbelt’s cash plans, spelled out in the filing after the buyback and U.S. relisting were announced. The timeline tightens from here: fiscal third-quarter results land March 12, with an investor day set for March 26.

The first week’s buying all took place on the London Stock Exchange, according to the report. Using the daily weighted average prices from those disclosures, the total value of shares bought so far came in around 36.2 million pounds. Sunbelt put the number of shares still outstanding after those transactions at 413.3 million.

Sunbelt shares started trading on the New York Stock Exchange on March 2, following a share swap that saw former Ashtead holders issued one Sunbelt share for every Ashtead share. CEO Brendan Horgan described the transition as putting the company “well positioned to support the next generation of infrastructure.” Finance chief Alex Pease expects the NYSE listing to “increase our visibility among institutional and retail investors.” The equipment rental group says it operates with 24,000 employees, runs more than 1,600 locations, and controls a fleet valued at over $19 billion. Sunbelt Rentals Holdings, Inc.

Scale still rules here. Sunbelt ranks just behind United Rentals as the No. 2 U.S. equipment rental name by market share, while Herc is going after growth through its H&E Equipment Services acquisition—stepping in after United dropped out of the running.

Shares of Sunbelt on the New York exchange traded up 1.25%, hitting $75.36 in delayed action Monday, LSEG data showed on Reuters.

Conditions remain uneven. In June, Ashtead pointed out that strength in data center, semiconductor, and liquefied natural gas (LNG) projects was making up for softness in U.S. commercial construction. High interest rates and lingering supply chain issues, though, kept non-residential demand under pressure.

Back in December, the company rolled out its $1.5 billion buyback alongside a half-year profit update that fell short of forecasts—higher repair expenses combined with a drop in hurricane activity weighed on the numbers. Despite the miss, it stuck to its full-year guidance.

The buyback leaves the bigger growth question hanging. If Thursday’s numbers show that the big-project pipeline can’t make up for sluggish commercial construction—or weather work stays quiet—investors could start looking past the cash handout and zero in on demand. That’s the read from the company’s June guidance and December update before this week’s earnings call.

Stock Market Today

  • JetBlue Airways Surpasses Analyst Target Price of $6.00
    May 15, 2026, 7:04 AM EDT. JetBlue Airways (JBLU) shares recently exceeded the average analyst 12-month target price of $6.00, trading at $6.03. This milestone prompts analysts to either revise targets upward or reconsider valuations. Eleven analysts contribute to the average, with targets ranging from $3.00 to $9.00, and a standard deviation of $2.05. Analyst ratings show a mixed sentiment: 2 strong buys, 6 holds, and 4 sell ratings. The average rating is 3.25, where 1 indicates strong buy and 5 strong sell. Investors are now advised to reassess JetBlue's prospects to determine if further gains or profit-taking are warranted.

Latest articles

US Stock Market Today: Nasdaq Futures Slide as Oil Shock and Treasury Yields Hit Wall Street

US Stock Market Today: Nasdaq Futures Slide as Oil Shock and Treasury Yields Hit Wall Street

15 May 2026
U.S. stock futures dropped early Friday, with Nasdaq 100 E-minis down 1.56% and S&P 500 E-minis off 1.07%, as Treasury yields and oil prices surged. Brent crude climbed to $109.19 after Donald Trump warned Iran, while the 10-year Treasury yield hit 4.54%. April retail sales rose 0.5%, dampening hopes for a Fed rate cut. Beijing summit produced no clear breakthrough on Iran.
MRNO Stock Just Jumped Before the Bell. The Bigger Murano Global Test Is Still Ahead

MRNO Stock Just Jumped Before the Bell. The Bigger Murano Global Test Is Still Ahead

15 May 2026
Murano Global Investments shares surged 67% to $0.49 in U.S. premarket trading Friday on heavy volume, after weeks under pressure from debt issues and a Nasdaq listing warning. The stock closed at $0.29 Thursday and faces an Oct. 5 deadline to regain compliance with Nasdaq’s $1 minimum bid rule. Murano is late filing its annual report and has warned of “substantial doubt” about its ability to continue as a going concern.
Mobix Labs Stock Soars 79% After Rare-Earth Deal Plan — Why MOBX Is Suddenly in the China Supply-Chain Fight

Mobix Labs Stock Soars 79% After Rare-Earth Deal Plan — Why MOBX Is Suddenly in the China Supply-Chain Fight

15 May 2026
Mobix Labs shares jumped 78.74% to $3.11 Thursday after it signed a non-binding letter of intent to acquire Special Project Delivery, a U.S. critical-minerals and energy-storage platform. The company also amended a convertible note with Leviston Resources, raising principal to $4 million for $833,000 in new cash. SPD was formed in 2019 and is based in Newport Beach, California.
HCW Biologics Stock News: Profit, Pipeline and Nasdaq Risk Put HCWB Back in Focus

HCW Biologics Stock News: Profit, Pipeline and Nasdaq Risk Put HCWB Back in Focus

15 May 2026
HCW Biologics posted first-quarter net income of $3.47 million on $6.54 million in revenue, reversing a year-earlier loss, after a licensing deal with Beijing-based Trimmune Biotech. The company remains below Nasdaq’s $1 minimum bid and awaits early human data from its lead autoimmune drug, HCW9302, in alopecia areata. HCW also reported positive animal study results for a lung drug targeting premature infants.
Unilever PLC Shares Slip as Oil Shock Revives 2026 Growth Doubts After Magnum Spin-Off
Previous Story

Unilever PLC Shares Slip as Oil Shock Revives 2026 Growth Doubts After Magnum Spin-Off

International Consolidated Airlines Group SA slides as oil shock and BA flight disruption threaten recovery
Next Story

International Consolidated Airlines Group SA slides as oil shock and BA flight disruption threaten recovery

Go toTop